Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study

NCT02028546

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations: Skin Center, Faculty of Medicine, Srinkharinwirot University Bangkok, Thailand

View Trial Details

Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

NCT01856621

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Orion Pharma Clinical Pharmacology Unit Espoo, Finland

View Trial Details

Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

NCT01766843

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Orion Pharma Clinical Pharmacology Unit Espoo, Finland

View Trial Details

Completed

E-nose and Inflammatory Asthma Phenotypes

NCT02026336

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations: Vicente Plaza Barcelona, Spain

View Trial Details

Completed

Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.

NCT01233284

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.380.43002 Boehringer Ingelheim Investigational Site Hallein, Austria

205.380.43004 Boehringer Ingelheim Investigational Site Linz, Austria

205.380.43005 Boehringer Ingelheim Investigational Site Neumarkt am Wallersee, Austria

205.380.43001 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria

View all 19 locations

View Trial Details

Completed

Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

NCT00350207

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.342.43002 Boehringer Ingelheim Investigational Site Graz, Austria

205.342.43004 Boehringer Ingelheim Investigational Site Trofaiach, Austria

205.342.43001 Boehringer Ingelheim Investigational Site Vienna, Austria

205.342.43005 Boehringer Ingelheim Investigational Site Vienna, Austria

View all 109 locations

View Trial Details

Completed

Comparison of Two Medication Adherence Strategies to Improve Asthma Treatment Adherence

NCT00115323

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

NCT00936624

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

NCT00584987

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy

NCT01777438

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: ORL Leuven, Vlaams-Brabant, Belgium

UZ Leuven Leuven, Vlaams-brabant, Belgium

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions